"Checking the Benefits of Bruhtyadi Vati in People with High Cholesterol (Dyslipidemia)"

Phase 1

Not yet recruiting

• Conditions: Mixed hyperlipidemia. Ayurveda Condition: MEDOJA-VRUDDHIH,

• Registration Number: CTRI/2025/05/087052
• Lead Sponsor: DrNileshkumar Samarjit Tiwari

Brief Summary

Dyslipidemia is a major risk factor for cardiovascular disease, the leading cause of deaths.

Currently available Hypolipidemic drugs are either expensive or often related to side effects. Hence there has been a pursuit for new safe and effective polyherbal drug for Dyslipidemia.

Detailed Description

Not available

Study Timeline

• Study Start: 2025-01-07
• Last Update Posted: 2025-08-05

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 106

Inclusion Criteria

• Age group having 25 to 60 years of age.
• Obese Dyslipidemic and Non-Obese Dyslipidemic Patients (BMI-18.50 to 40.00 kg/m2) as per latest Updated WHO classification of BMI).
• According to NCEP ATPIII Classification, the Pilot Project Study by Prevalence in local area and with the guidelines of CCRAS for Dyslipidemia; following were the levels to be selected for said Project.
• Patient having Serum Total Cholesterol Level 200-239 mg/dl Patient having Serum LDL Cholesterol Level 130-159 mg/dl Patient having serum VLDL Cholesterol Level 40-60 mg/dl Patient having Serum HDL Cholesterol Level 20-40 mg/dl Patient having Serum Triglyceride Level 150-190 mg/dl Patients having one or more of above levels will be selected for said project.

Exclusion Criteria

• Pregnant and lactating mothers.
• Patients having Diabetes Mellitus.
• Patients having history of Respiratory Disease Complications, Coronary Heart disease, Renal Disease Patients having Acute Complications like Severe Hypertension (B.P 150/90 mm Hg in those with age 60 years and older, and 140/90 mm Hg for adults less than 60 years.
• according to Eighth Joint National Committee Guideline), Hepatitis or with history of major surgery etc.
• Patients having disorders like Carcinoma anywhere in the body etc.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in Lipid Profile by Bruhatyadi Vati towards the Normal levels.	Outcome will be assessed at baseline, 4 weeks & 8 weeks

Trial Locations

Locations (1)

R.A Podar Medical College (Ayu); 🇮🇳 Mumbai, MAHARASHTRA, India

R.A Podar Medical College (Ayu)

🇮🇳Mumbai, MAHARASHTRA, India

Dr Nileshkumar Tiwari

Principal investigator

8983074408

dr.nileshtiwari@gmail.com